Centauri Therapeutics

About Centauri Therapeutics

Centauri Therapeutics is an immunotherapy company focused on infectious diseases and oncology. The company leverages its Alphamer platform to redirect naturally existing antibodies, enabling novel bifunctional immunotherapies for life-threatening infections and cancer. Based in the United Kingdom, Centauri combines preclinical and clinical development to advance therapies for vulnerable patient populations. Their work includes advancing lead compounds and publishing proof-of-concept data.